Search

everythinglearnresearchcommunity

for

Search:↓

Alopecia areata patients show increased inflammation and OX40 activation, suggesting a new treatment target.

Topical corticosteroids may be a safe and effective treatment for severe alopecia areata in children.

Patients with severe active alopecia areata have lower CD200 expression and an imbalance in their immune system.

The document concludes that DAB389-IL2 is promising for treating refractory cutaneous T-cell lymphoma, but more research is needed on its effectiveness and side effect management.

Contact immunotherapy can cause vitiligo in patients with autoimmune conditions.

Higher levels of certain proteins in the blood are linked to more severe patchy alopecia areata.

Alopecia areata is an autoimmune disease that targets hair follicles.

The research developed methods to test drugs that could protect and restore hair follicle protection in a hair loss condition.

Enhancing regulatory T cells may help treat autoimmune diseases like alopecia areata.

Triamcinolone acetonide injections effectively treat skin disorders like eczema and psoriasis.

Patients with a specific genetic variant have more severe alopecia areata and higher recurrence rates.

A woman's rare adrenal tumor caused high testosterone and cortisol levels, which normalized after the tumor was removed.

Serum steroid profiling, especially 11-deoxycortisol, helps distinguish between adrenocortical carcinoma and adenoma, considering sex and functional status.

Careful patient selection is key for effective pulse corticosteroid treatment in children with alopecia areata.

Certain CD8+ T cells attack hair follicles in alopecia areata, suggesting they could be targeted for treatment.

TCA injections are more effective and safer than cryotherapy for treating alopecia areata.

Tocilizumab treatment was associated with significant hair regrowth in one patient and temporary hair loss followed by regrowth in another.

People with alopecia areata have fewer regulatory T-cells than those with other skin conditions.

Alopecia areata is an autoimmune disease causing hair loss, and targeting macrophages may help treat it.

Steroid injections are more effective than platelet rich plasma for treating patchy hair loss.

Alopecia areata was successfully treated with contact immunotherapy, oral antihistamines, and topical corticosteroids.

High-dose corticosteroids can significantly regrow hair in severe alopecia areata.

An 8-year-old boy with hair loss had hair regrowth and responded well to clobetasol propionate treatment.

Most patients improved in both atopic dermatitis and alopecia areata with certain treatments, but some had worsened symptoms, suggesting personalized care is needed.

Alopecia areata is linked to immune system differences, with specific biomarkers like CXCL9 and CXCL10 being key for diagnosis and potential treatment targets.

Adults with atopic dermatitis showed similar adherence to different forms of hydrocortisone cream, but actual use varied despite self-reports of near-perfect usage.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

IL-17 and certain immune cells are linked to more severe alopecia areata.

Targeting CXCL10 may help treat alopecia areata.